Variant ID | 6035 |
---|---|
Entrez Gene ID | 8821 |
Gene | INPP4B (GeneCards) |
Location | hg19 4:143900592-143900592
hg38 4:142979439-142979439 |
Disease | Asymptomatic |
Method | HiSeq X Ten |
Mutation(HGVS format) | NC_000004.11:g.143900592 G>A (Genome Assembly: GRCh37) |
Exon or Intron | NA |
---|---|
Position in protein | NA |
Amino acid changes in protein | NA > NA |
Position in cDNA | NA |
Changes in cDNA | NA > NA |
mRNA accession | NA |
mRNA length | NA |
Reference length | 191154276 |
MAF in gnomAD genome (version 2.0.1) | 0 |
---|---|
EIGEN score | -0.0603 |
CADD Raw score (version 1.3) | -0.11943 (Deleterious) |
FATHMM raw prediction score | 0.14328 (Tolerated) |
Deleterious probability by DeFine | 0.3817 (Neutral) |
Entrez Gene ID | 8821 (NCBI Gene) |
---|---|
Official Gene Symbol | INPP4B (GeneCards) |
Number of variants in INPP4B in this database | 7 (view all the variants) |
Full name | inositol polyphosphate-4-phosphatase type II B |
Band | 4q31.21 |
Other IDs | Vega: OTTHUMG00000161341 OMIM: 607494 HGNC: HGNC:6075 Ensembl: ENSG00000109452 |
Other names | None |
Summary | INPP4B encodes the inositol polyphosphate 4-phosphatase type II, one of the enzymes involved in phosphatidylinositol signaling pathways. This enzyme removes the phosphate group at position 4 of the inositol ring from inositol 3,4-bisphosphate. There is limited data to suggest that the human type II enzyme is subject to alternative splicing, as has been established for the type I enzyme. [provided by RefSeq, Jul 2008] |
Individual ID | 29217584.03 (view all the variants in this individual) |
---|---|
Pubmed ID | 29217584 |
Whose mosaic mutation | Normal |
Phenotype | 1 |
Disease | Asymptomatic |
OMIM ID |
Pubmed ID | 29217584 |
---|---|
Title | Aging and neurodegeneration are associated with increased mutations in single human neurons. |
Journal | Science |
Publication date | 2018.02 |
Disease | Cockayne syndrome Xeroderma Pigmentosum |
Number of cases | Male cases: 3; Female cases: 6; cases of unknown sex: 15; |